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Abstract
Scope
First- and second-generation antipsychotics (FGAs and SGAs, respectively), both inhibit
cholesterol biosynthesis and impair the intracellular cholesterol trafficking, leading to lipid
accumulation in the late endosome/lysosome compartment. In this study we examined if
curcumin, a plant polyphenol that stimulates exosome release, can alleviate antipsychotic-
induced intracellular lipid accumulation.
Methods
HepG2 hepatocarcinoma cells were treated with antipsychotics or placebo and DiI-labelled
LDL for 18 h and then exposed to curcumin for the last 2 h. Cells and media were collected
separately and used for biochemical analyses, electron microscopy and immunocytochem-
istry. Exosomes were isolated from the incubation medium by ultracentrifugation.
Results
Curcumin treatment reduced the number of heterolysosomes and shifted their subcellular
localization to the periphery, as revealed by electron microscopy, and stimulated the
release of lysosomal β-hexosaminidase and exosome markers flotillin-2 and CD63 into the
media. The presence of DiI in exosomes released by cells preloaded with DiI-LDL demon-
strated the endolysosomal origin of the microvesicles. Furthermore, curcumin increased the
secretion of cholesterol as well as LDL-derived DiI and [3H]-cholesterol, in association with
a decrease of intracellular lipids. Thus, the disruption of lipid trafficking induced by FGAs or
SGAs can be relieved by curcumin treatment. This polyphenol, however, did not mitigate
the reduction of cholesterol esterification induced by antipsychotics.
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Conclusion
Curcumin stimulates exosome release to remove cholesterol (and presumably other lipids)
accumulated within the endolysosomal compartment, thereby normalizing intracellular lipid
homeostasis. This action may help minimize the adverse metabolic effects of antipsychotic
treatment, which should now be evaluated in clinical trials.
Introduction
Antipsychotic drugs are widely used to alleviate a number of psychiatric disorders. There are two
classes of antipsychotic drugs, typical or first-generation antipsychotics (FGAs) and atypical or
second generation antipsychotics (SGAs). The therapeutic efficacy of both classes is strongly asso-
ciated with antagonism of D2 dopamine receptors [1], SGAs exhibiting lower affinity for D2
receptors and greater affinity to serotonergic, histaminergic, muscarinic, and adrenergic receptors
than FGAs [1]. Both classes of antipsychotics are associated with serious side effects. The most
salient side effects of most antipsychotic are acute and chronic extrapyramidal symptoms or
movement disorders. The SGAs show reduced incidence of such neurological side effects but the
blockade of other neurotransmitter receptors is thought to underline other adverse effects [2,3].
Recently, a higher risk of stroke in antipsychotic users has been reported, especially in older
patients with vascular illness, although the pathophysiology of such association is still unclear [4].
Antipsychotics have been also shown also to disrupt lipid homeostasis [5–9]. Both FGAs and
SGAs inhibit cholesterol biosynthesis in vitro by altering the activities of various enzymes in the
biosynthesis pathway, resulting in the accumulation of different sterol intermediates (the sub-
strates of the inhibited enzymes) depending on the specific drug and dose [5,6,8,10]. This alter-
ation in sterol profile affects lipid raft formation and consequently cell signaling triggered by
hormones as demonstrated for insulin and somatostatin in cells treated with haloperidol [5,10].
Antipsychotics also impair intracellular cholesterol trafficking and interfere with low-den-
sity lipoprotein (LDL)-derived cholesterol egress from the endosome/lysosome compartment,
thereby reducing the arrival of endocytosed LDL cholesterol to both the endoplasmic reticulum
(ER) [5,6,8] and the trans-Golgi [11]. Cholesterol reaching the ER can be esterified as a storage
form and/or sensed by the sterol-regulatory-element-binding protein (SREBP)-Scap-Insig sys-
tem [12]. The reduction in ER cholesterol is in accordance with the observed upregulation of
SREBP and downstream target genes in response to antipsychotic treatment [8,13]. Given that
excess free cholesterol is cytotoxic, lipid levels within the cell are tightly regulated. Complex
mechanisms have evolved to regulate cellular lipid abundance and distribution between cell
compartments by a feedback pathway that controls the synthesis, esterification, uptake, and
efflux of cholesterol [14]. However, exposure to antipsychotics has been shown to alter intracel-
lular lipid homeostasis, as it reduces cholesterol availability in the ER, increases LDL endocyto-
sis, and stimulates fatty acid and triglyceride biosynthesis [8].
Curcumin, the main active polyphenol extracted from the rhizome of Curcuma longa (Tur-
meric), has multiple beneficial effects against inflammation, hyperlipidemia, and atherosclero-
sis [15]. The mechanisms by which curcumin affects lipid metabolism appears to be diverse
[16]. Of noting, curcumin has been shown to potently elevate cytosolic free Ca2+ levels by
inhibiting sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) activity [17], which may affect
multiple cellular processes, including enzyme activity and vesicular trafficking [18,19]. In par-
ticular, regarding the intracellular lipid traffic, curcumin alleviated the accumulation of choles-
terol, sphingomyelin, and glycosphingolipids in the endocytic compartment characteristic of
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Niemann Pick disease type C (NPC) by restoring endocytic calcium depletion [20]. Moreover,
curcumin has been shown to stimulate LDL receptor (LDLR) at the levels of mRNA, protein
and activity in different cell types, included hepatocytes, lymphocytes, macrophages and renal
cells [21,22] although a suppression of LDLR gene expression was observed in stellate cells
[23]. Curcumin also stimulates cholesterol efflux mediated by ATP-binding cassette protein A1
(ABCA1) in adipocytes [24] and macrophages [25]. Finally, curcumin has been shown to stim-
ulate exosome secretion in a cellular model of NPC1 deficiency, thus reducing the intracellular
cholesterol accumulation [26].
Exosomes are small vesicles secreted by most cell types in culture. They are formed inside
the cell by inward budding of the limiting membranes of endocytic compartments, creating
vesicle-containing endosomes termed multivesicular bodies (MVBs). These MVBs can fuse
with the plasma membrane, thereby releasing their internal vesicles, exosomes, into the extra-
cellular space [27]. The secretion of exosomes is triggered by cytoplasm Ca2+ [28,29]. Exosomes
are involved in numerous physiological and pathological processes, including cell-cell commu-
nication by horizontal transfer of proteins and RNA, antigen presentation, tumor metastasis,
propagation of infectious agents, and release of superfluous membranes and cytosol [30]. In
addition, exosome release could function to eliminate undesired materials from the cell, such
as excess lipids [31]. Both oligodendrocytes treated with U18666A and NPC1-deficient fibro-
blasts combated cholesterol accumulation in the lysosomal compartment by increasing the
secretion of exosomes [32]. However, the potential of curcumin to attenuate antipsychotic-
induced disruption in lipid homeostasis by exosomal release has not been examined. Here we
show that curcumin promotes exosome release, thus reducing the late-endosome/lysosome
trapping of cholesterol induced by antipsychotic drugs.
Materials and Methods
All chemicals were purchased from Sigma (Sigma-Aldrich Química, S.A., Tres Cantos, Madrid,
Spain) unless otherwise stated. The antipsychotics used were clozapine free base, haloperidol free
base, risperidone free base, and ziprasidone hydrochloride (Tocris, Bristol, United Kingdom).
Cell culture
HepG2 hepatocarcinoma cells (ATCC HB-8065) (Rockville, MD, USA) were cultured in high-
glucose DMEM (Gibco, Life Technologies Corporation, Madrid, Spain) supplemented with
MEM non-essential amino acids, 10% fetal bovine serum (FBS), and antibiotics (Gibco) at
37°C in a 5% CO2 atmosphere. Lipoprotein-deficient serum (LPDS) was prepared from FBS by
ultracentrifugation at a density of 1.21 kg/L. Cells were cultured in medium with 10% LPDS
supplemented with LDL (60 μg/ml of cholesterol), and then incubated for 16 h with no drug
(control) or with an antipsychotic (clozapine, haloperidol, risperidone, or ziprasidone at
10 μM). Cells were then washed twice with PBS and incubated in serum-free medium with the
same antipsychotic with or without curcumin (30 μM) for an additional 2 h. Drugs were dis-
solved in DMSO (dimethyl sulfoxide; final concentration in the medium, 0.044%). Control
cells were exposed to the solvent. Human LDL, isolated as described [33], was labeled with the
fluorescent probe 1,10-dioctadecyl-3,3,3,30-tetramethylindocarbocyanineperchlorate (DiI, Life
Technologies Corporation) as previously described [34]. Cell viability was determined using
XTT assays (cell proliferation kit; Roche, Mannheim, Germany).
Immunofluorescence microscopy
HepG2 cells were cultured on glass coverslips, treated as indicated, and fixed with 4% parafor-
maldehyde (PFA)/PBS for 5 min. Fixed cells were permeabilized in 0.1% Triton X-100/PBS for
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5 min and blocked with 2% bovine serum albumin in PBS for 45 min. For free cholesterol stain-
ing, cells were exposed to filipin (50 mg/L in PBS) for 45 min. Cells were stained with anti-
CD63 (1/200, Ref 55619, BD Biosciences, Madrid, Spain) at a 1:200 dilution for 2 h, followed
by incubation with Alexa fluor-conjugated IgG (Molecular Probes, Life Technologies Corpora-
tion) in PBS at a 1:500 dilution for 45 min. Cells were mounted for microscopy and examined
on a Nikon D Eclipse C1 confocal microscope.
Intracellular DiI-LDL accumulation by flow cytometry
DiI-LDL uptake was assayed as previously described [35]. Cells were incubated with DiI-LDL
(30 μg cholesterol/ml) and the intracellular content was analyzed by a FACSscan flow cytome-
try system (BD Biosciences). Non-specific accumulation was determined in extra tubes con-
taining DiI-LDL and a 50-fold excess of unlabelled LDL. Results are expressed as specific
median intensity of fluorescence (M.I.F.) after subtracting autofluorescence from cells incu-
bated in the absence of DiI-LDL.
Cholesterol efflux assays
To measure cholesterol efflux, LDL was labeled with [3H]-cholesterol (Perkin-Elmer, Shelton,
CT, USA) following a previously published method [36] with minor modifications. Briefly, 2
ml of LDL (5 mg/ml) in 0.9% NaCl was added to [3H]-cholesterol (200 μCi; dried with N2) and
incubated at 4°C for 5–7 h with occasional mixing. Cells in 10% LPDS-containing medium
were incubated with [3H]-cholesterol-labeled LDL (60 μg/ml of cholesterol) for 16 h with or
without an antipsychotic (clozapine, haloperidol, risperidone, or ziprasidone at 10 μM). The
cells were then washed twice with PBS and cultured for 2 additional hours in serum-free
medium with the same antipsychotic with or without curcumin. The culture medium was har-
vested and the cell monolayer washed with PBS and treated with 0.1 M NaOH to extract total
intracellular [3H]-radioactivity. Radioactivity was counted with a liquid scintillation analyzer
(Tri-Carb 2800TR, Perkin Elmer). The cholesterol efflux was calculated as the percent of [3H]-
cholesterol released into the medium.
Analysis of cholesterol by gas chromatography/mass spectroscopy (GC/
MS)
Sterols were extracted using chloroform:methanol (2:1, vol/vol) and analyzed using an Agilent
6890N GC and an Agilent 5975 MS detector (Agilent Technologies, Santa Clara, CA, United
States) with an Agilent DB-5ms, 30 m × 0.25 mm × 0.1 μm column [5,8]. For quantitation, the
MS detector was operated in selective ion monitoring (SIM) mode following at least one quan-
tifier and two qualifying ions for each sterol. Peak identification was achieved both by compari-
son with known external standards and by monitoring characteristic ions.
Measurement of [3H]oleic acid incorporation into cholesteryl esters
The cells in 10% LPDS-containing medium were incubated for 16 h with or without an antipsy-
chotic (clozapine, haloperidol, risperidone, or ziprasidone at 10 μM). Then they were washed
twice with PBS and cultured for 2 additional hours in serum-free medium with the same anti-
psychotic with or without curcumin. An emulsion of 1.3 μCi [9,10-3H]oleic acid per well (50
Ci/mmol, Hartmann Analytic GmbH, Braunschweig Germany) containing 0.15% human
serum albumin, was added to the medium the last 2 h. Then the lipids extracts were analyzed
by high performance liquid chromatography (HPLC) using an Agilent HPLC system consisted
of a 1260 LC quaternary pump a 1260 injector, a 1260 oven set at 40°C, and a Agilent 1200
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evaporative light scattering detector set to gain 4, drift tube temperature 45°C and 3.0 bar inter-
nal nitrogen pressure with a Kinetex-HILIC column (2.6 μm, 100 x 46 mm, Phenomenex) and
a guard cartridge (HILIC, 4.6 mm, Phenomenex) as described in detail by [37]. The cholesterol
ester fraction was collected, dried and the radioactivity was counted.
Exosome isolation and analysis
Exosomes were isolated from culture media as previously described [38]. Briefly, after treating
the cells (5 × 106/dish), the medium was collected on ice, centrifuged at 800 × g for 10 min to
sediment cells and then twice at 12,000 × g for 30 min to sediment debris. Exosomes were sedi-
mented from the remaining supernatant by ultracentrifugation at 100,000 × g for 2 h. The exo-
some pellet was resuspended in PBS. The purity of the exosome preparation was evaluated by
analyzing the content of an ER marker, calnexin, by Western blot, which was barely detected in
every exosome preparation [26].
Late endosome exocytosis was quantitated by measuring the activity of β-N-acetylglucosa-
minidase (β-hexosaminidase), a lysosomal enzyme, in the medium of HepG2 cells using a β-N-
acetylglucosaminidase assay kit. Enzyme released into the medium was expressed as a percent-
age of the total (medium plus that in lysed cells).
For Western blot analysis, cell lysates were loaded at 20–30 μg protein per gel lane and exo-
some samples at the maximum lane well volume. Samples were solubilized in reducing SDS
loading buffer, separated on 8%–10% SDS-PAGE, and transferred to nitrocellulose membranes
(Bio Rad Laboratories S.A., Barcelona, Spain). After blocking, the membranes were probed
with specific antibodies for flotillin-2 (1/500, Ref 610383 BD Biosciences), CD63 (1/300,
H193), and β-actin (1/3000, I-19) as the gel loading control (Santa Cruz Biotechnology), fol-
lowed by incubation with secondary antibodies conjugated to IRDye 800CW or IRDye 680LT
(LI-COR, Lincoln, NE, USA) in the dark. Immunolabeling was detected using the Odyssey
Infrared Imaging System (LI-COR).
Exosome bead fluorescence-activated cell sorting (FACS)
Exosomes obtained from HepG2 cells incubated with DiI-LDL were absorbed onto 4 μm alde-
hyde-sulfate latex beads (Invitrogen, Life Technologies Corporation) and incubated first with
CD63 antibody (1/200, Ref 55619, BD Biosciences) and then with a fluorophore-conjugated
secondary antibody. Cells were washed and analyzed by flow cytometry (FACSscan, BD Biosci-
ences) as previously described [39].
Electron microscopy
Following drug treatment, cells were fixed in 2% glutaraldehyde for 1 h and with 4% PFA for 1
h. Fixed cells were washed with sodium phosphate buffer, post-fixed with 1% osmium tetroxide
for 1 h, dehydrated in increasing concentrations of ethanol, and embedded in epoxy resin
(Fluka, Sigma-Aldrich). Ultrathin sections were prepared, stained with uranyl acetate and lead
citrate, and examined under a JEOL JEM1010 transmission electron microscope (JEOL Ltd.,
Tokyo, Japan).
Exosome preparations were fixed in 2% PFA and loaded onto Formvar1 carbon coated
grids (Thermo Fisher Scientific, Rochester, NY, USA). Then, the exosomes were post-fixed in
1% glutaraldehyde, washed, contrasted in 2% uranyl acetate, embedded in a mixture of uranyl
acetate (0.8%) and methyl cellulose (2%), and examined in a JEOL JEM1010 electron
microscope.
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Statistical Analysis
Data are shown as mean ± SEM. Treatment group means were compared by two-way repeated
measures ANOVA followed by post hoc Bonferroni tests for multiple comparisons using
GraphPad Prism 6 software. In all cases, a confidence level of 5% was considered statistically
significant (P< 0.05).
Results
Changes in HepG2 cell ultrastructure induced by antipsychotics and
mitigation by curcumin
In this study we used the HepG2 cells for the intense lipid metabolism of hepatocytes and the
involvement of liver in the metabolism of antipsychotics. Antipsychotic interfere with LDL-
derived cholesterol egress from the endosome/lysosome compartment and thereby induced
intracellular lipid accumulation [5,8,10]. To determine whether curcumin alleviates the intra-
cellular lipid accumulation induced by antipsychotics, in preliminary experiments we analyzed
the effects of different concentrations of curcumin on the intracellular accumulation of LDL
induced by 10 μM haloperidol. For this, the cells were incubated in the presence of DiI-LDL for
16 h and, then the medium was replaced by a fresh one without DiI-LDL and the cells were
incubated with curcumin (5, 10, 30 and 40 μM) for additional 2 h, always in the absence (con-
trol) or the presence of haloperidol (Fig A in S1 File). The results revealed that 30 and 40 μM of
curcumin concentration reduced DiI-LDL accumulation in cells treated with haloperidol (Fig
A in S1 File). Therefore we decided to select the dose of 30 μM curcumin for the following
experiments.
The HepG2 cells were incubated in medium containing LDL and one of the following anti-
psychotics (10 μM): haloperidol (an FGA), clozapine, risperidone, or ziprasidone (SGAs) dur-
ing 18 h. Where indicated, cells were treated with curcumin (30 μM) for the last 2 h of
incubation. Treatment of HepG2 cells without (control) or with 30 μM curcumin (2 h) had no
appreciable effect on cell proliferation as measured by the XTT assay (Control = 100.0 ± 4.5
and curcumin = 100.6±3.0 a.u.f.; mean ± SEM, n = 3).
Ultrastructural analysis of untreated control HepG2 cells revealed relatively few lysosomes
and marked morphological heterogeneity of mitochondria (Fig 1). In general, the main effect
of antipsychotic treatment was the increase in the number of heterolysosomes or MVB. Lipid
inclusions, secondary lysosomes, and abnormal mitochondria also were observed (Fig 1 and
Fig B in S1 File). These results are in accordance with our previous fluorescence microscopy
study showing altered intracellular LDL trafficking in HepG2 cells treated with FGAs or SGAs
[5,8]. Subsequent treatment with curcumin for 2 h in the continued presence of the antipsy-
chotic reduced the number of heterolysosomes and secondary lysosomes (Fig 1 and Fig B in S1
File). Altogether, the results suggested that curcumin promotes the removal of material accu-
mulated within heterolysosomes.
Mitigation of the antipsychotic-induced lysosomal accumulation of
cholesterol by curcumin
We thus analyzed the effects of curcumin on the intracellular accumulation of LDL induced by
the antipsychotics. For this, the cells were incubated in the presence of DiI-LDL for 16 h and,
then the medium was replaced by a fresh one without DiI-LDL and the cells were incubated
with curcumin 30 μM for additional 2 h, always in the absence (control) or the presence of the
antipsychotic. Cells treated with antipsychotics exhibited increased filipin staining in bright
perinuclear granules compared to the control, indicative of cholesterol accumulation. These
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Fig 1. Electronmicrographs of HepG2 cells untreated (control) or treated with an antipsychotic (haloperidol or ziprasidone at 10 μM) and LDL
(60 μg/ml of cholesterol) for a total of 18 h.Where indicated, during the last 2 h, the cells were treated with 30 μM curcumin. Images are representative
from 2 independent experiments. Lysosomes (▲), lipid inclusions (§), heterolysosomes or MVB (*).
doi:10.1371/journal.pone.0141829.g001
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granules were positive for CD63 (Fig 2A) and contained DiI, indicating that the free cholesterol
was derived from internalized DiI-LDL and accumulated in the late endosome/lysosome com-
partment. When cells were challenged with curcumin for the last 2 h, a decrease in the size of
granules positive for DiI, filipin, and CD63 was observed in cells treated with antipsychotics.
Of note, abundant DiI- and filipin-positive vesicles appeared at the cell periphery (Fig 2B).
Studies by flow cytometry revealed that curcumin reduced DiI-LDL accumulation in cells
treated with an antipsychotic (Fig 3), confirming that this polyphenol ameliorates the intracel-
lular cholesterol trafficking block.
Curcumin enhanced cholesterol secretion from antipsychotic-treated
cells
To determine the effects of curcumin on cholesterol efflux, HepG2 cells maintained in LPDS
medium were treated with an antipsychotic (clozapine, haloperidol, risperidone, or ziprasi-
done) plus 3H-cholesterol-labeled LDL or left untreated for 16 h, washed in PBS, and incubated
for 2 h with serum-free medium containing the same antipsychotic with or without curcumin.
At end of the incubation, 3H-cholesterol was measured in both cells and media. In antipsy-
chotic treated cells, curcumin enhanced the cholesterol efflux outside the cells (Fig 4). In sepa-
rate experiments, we determined the total cholesterol in HepG2 cells at the end of incubation.
In HepG2 cells incubated in the presence of LDL and an antipsychotic for 16 h, subsequent
Fig 2. Effects of curcumin on the intracellular distribution of LDL in cells treated with antipsychotics. (A) HepG2 cells were exposed to DiI-LDL
(30 μg/ml of cholesterol) in the absence (control) or the presence of antipsychotic (haloperidol, clozapine, risperidone, or ziprasidone, 10 μM) for a total of 18
h. The cells were then washed, fixed, stained with filipin and anti-CD63, and analyzed by confocal microscopy. Representative results from 3 independent
experiments are shown. (B) Cells were exposed to DiI-LDL in the absence (control) or the presence of antipsychotic (10 μM) for a total of 18 h and curcumin
(30 μM) was added for the last 2 h. The cells were then washed, fixed, stained with filipin and anti-CD63, and analyzed by confocal microscopy.
Representative results from 3 independent experiments are shown.
doi:10.1371/journal.pone.0141829.g002
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treatment with curcumin significantly reduced the total intracellular cholesterol content
(Table A in S1 File). Given that cells were incubated in the absence of cholesterol acceptors (i.e.
ApoA1 [apolipoprotein A1] or HDL), these results suggest that mechanism(s) different than
those mediated by ABC-transporters must account for the promotion of cholesterol release by
curcumin.
Fig 3. Effect of curcumin on the intracellular DiI-LDL accumulation in cells treated with
antipsychotics.HepG2 cells were incubated with DiI-LDL (30 μg/ml of cholesterol) for 16 h in the absence
(control) or the presence of haloperidol (Hal), clozapine (Clo), risperidone (Ris), or ziprasidone (Zip) (10 μM).
Then, cells were washed and serum-free medium containing the same antipsychotic with or without 30 μM
curcumin was added and incubated for additional 2 h. Intracellular DiI-LDL was measured by flow cytometry.
Results are mean ± SEM of three independent experiments performed in duplicate. M.I.F., median intensity
of fluorescence; a.u.f., arbitrary units of fluorescence. Statistical comparisons shown are curcumin versus no
curcumin (* P<0.05, ** P<0.01 and *** P<0.001) and antipsychotic versus untreated control (+ P<0.05, ++
P<0.01, +++ P<0.001 and ++++ P<0.0001).
doi:10.1371/journal.pone.0141829.g003
Fig 4. Curcumin increases LDL-derived cholesterol efflux in HepG2 cells treated with antipsychotics.
HepG2 cells were exposed to 3H-cholesterol-labeled LDL (60 μg/ml of cholesterol) for 16 h in the absence
(control) or presence of haloperidol (Hal), clozapine (Clo), risperidone (Ris), or ziprasidone (Zip) (10 μM).
Cells were washed twice and serum-free medium was added containing the same antipsychotic with or
without 30 μM curcumin, as indicated, and the cells were incubated for additional 2 h. Finally, 3H-radioactivity
was measured in both the cells and medium. The 3H-cholesterol efflux into the medium is expressed as the
percentage of total radioactivity in the well (cells plus medium). Results are mean ± SEM of three
independent experiments performed in duplicate. Statistical comparisons shown are curcumin versus no
curcumin (* P<0.05, ** P<0.01 and *** P<0.001).
doi:10.1371/journal.pone.0141829.g004
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Curcumin-induced secretion of endosomal/lysosomal proteins from
antipsychotic-treated cells
To determine whether curcumin induces late-endosome exocytosis in antipsychotic-treated
HepG2 cells, we measured the lysosomal enzyme β-hexosaminidase in the culture media (Fig
5A). In cells treated with antipsychotic, curcumin significantly increase the release of β-hexosa-
minidase activity to the culture. In addition, curcumin enhanced the secretion of proteins con-
sidered as markers for exosomes, as indicated by Western blotting of lysates from HepG2 cells
and isolated exosomes (Fig 5B and 5C). Treatment with curcumin significantly increased the
content of both flotillin-2 and CD63 in the exosome fraction, while no significant changes in
the content of these proteins were detected in cell lysates.
As examined by electron microscopy, secreted exosomes had a rounded structure with a
median diameter of 67.5 nm (data not shown), which is too small as to be reliably analyzed by
FACS directly. Thus, for this study, isolated exosomes were fixed to aldehyde sulfate-latex
beads of a size within the detection range of a flow cytometer [38,39], and exosome-bound
CD63 and DiI were measured by flow cytometry. As shown in Fig 6, curcumin treatment sig-
nificantly increased the release of both CD63 and DiI bound to exosomes from cells treated
with antipsychotics. Moreover, curcumin also increased cholesterol levels in isolated exosomes
released from antipsychotic-treated HepG2 cells compared to exosomes from control cultures
as measured by GC/MS (Table 1).
Taken together, these results show that curcumin promotes exosome secretion from anti-
psychotic-treated HepG2 cells. The higher cholesterol content of these exosomes following cur-
cumin treatment strongly indicate that curcumin promotes lipid egress from the cell, thereby
alleviating endosomal/lysosomal cholesterol deposition caused by antipsychotic-induced inhi-
bition of intracellular lipid trafficking.
Effects of curcumin on cholesterol esterification
Cholesterol in the ER can be esterified by acyl-coenzyme A:cholesterol acyltransferase (ACAT)
for storage [14]. We determined the [3H]oleic acid incorporation into cholesteryl esters as a
measure of cholesterol availability in the ER. As shown in Fig 7, treatment with antipsychotics
reduced cholesterol esterification compared to control, an effect that was statistically significant
for clozapine, risperidone and ziprasidone, but not for haloperidol. The esterification rate was
not affected by curcumin, suggesting that curcumin did not increase the availability of free cho-
lesterol in the ER. Thus, the reduction of cholesterol accumulation within the endolysosomal
compartment induced by this polyphenol is achieved via exosome secretion rather than egress
to the ER.
Discussion
Prolonged treatment with antipsychotics may be accompanied by adverse effects like weight
gain, dyslipidemia, and insulin resistance as shown in both patients with schizophrenia and
older people with dementia [2,3]. Antipsychotics, both FGAs and SGAs, have been shown to
inhibit cholesterol synthesis and to induce intracellular lipid accumulation in late endosomes
in different cell lines [5,6,8]. These effects could underlie some of the metabolic adverse effects
induced by prolonged treatment with antipsychotic [8]. Due to the array of deleterious conse-
quences this may have on patients, we investigated the possibility of alleviating the intracellular
LDL trafficking inhibition and lipid accumulation induced by antipsychotics. In this study, we
demonstrate that the natural turmeric-derived polyphenol promotes cholesterol clearance
from antipsychotic-treated cells.
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Fig 5. Curcumin enhances the release of lysosomal β-hexosaminidase (A) and flotillin-2- and
CD63-containing exosomes (B and C) from HepG2 cells treated with antipsychotics.Cells were
exposed to LDL (60 μg/ml of cholesterol) in the absence (control) or the presence of haloperidol (Hal),
clozapine (Clo), risperidone (Ris), or ziprasidone (Zip) (10 μM) for 16 h. Cells were washed twice and then
incubated for additional 2 h in serum-free medium containing the same antipsychotic with or without curcumin
(Cur, 30 μM) as indicated. (A) At the end of the incubation, the activity of the lysosomal enzyme β-
hexosaminidase was measured in both cells and medium. The enzyme activity released into the medium is
expressed as the percentage of total enzyme content (cells plus medium). Results are mean ± SEM of three
independent experiments performed in triplicate. (B and C) At the end of the incubation, the medium was
removed, and isolated exosomes and cell lysates analyzed byWestern blot. (B) Flotillin-2, CD63, and actin
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We first studied the ultrastructural changes in HepG2 cells induced by antipsychotics. Both
haloperidol, a FGA, and three SGAs, clozapine, risperidone, and ziprasidone, induced pro-
found changes in subcellular organelles, including increased numbers of heterolysosomes or
MVBs containing electron-dense material. This finding was in accordance with the profusion
of late endolysosomes observed by immunocytochemical analysis. Strikingly, curcumin treat-
ment reduced the number of heterolysosomes in cells treated with antipsychotics. To assess
Western blots from exosome and HepG2 cell lysate. Results are representative of 3 independent
experiments. (C) Quantitation of exosomal release of flotillin-2 (Flot-2) and CD63 from HepG2 cells. Results
are mean ± SEM of three independent experiments; the control without curcumin is normalized to 1.
Statistical comparisons shown are curcumin versus no curcumin (* P<0.05, ** P<0.01, *** P<0.001 and
**** P<0.0001).
doi:10.1371/journal.pone.0141829.g005
Fig 6. Curcumin increases CD63 surface expression and DiI-LDL content in isolated exosomes as
analyzed by FACS.HepG2 cells were incubated with antipsychotics (haloperidol [Hal], clozapine [Clo],
risperidone [Ris], or ziprasidone [Zip], 10 μM) and DiI-labeled LDL (60 μg/ml of cholesterol) for 16 h. Cells
were washed twice and serum-free medium containing the same antipsychotics with or without 30 μM
curcumin added as indicated. After a further 2-h incubation, exosomes were isolated from the medium,
attached to latex beads, labeled with anti-CD63, and analyzed by FACS. The graphs represent the
fluorescence of CD63 (MIF) (A) and DiI-LDL (Geometric Log means) (B) in exosomes. Results are
mean ± SEM of three independent experiments. M.I.F., median intensity of fluorescence; a.u.f., arbitrary units
of fluorescence. Statistical comparisons shown are curcumin versus no curcumin (* P<0.05, ** P<0.01, ***
P<0.001 and **** P<0.0001).
doi:10.1371/journal.pone.0141829.g006
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whether these phenotypic changes were due to the affectation of lipid homeostasis, we studied
the intracellular fate of endocytosed DiI-labeled LDL. Treatment with antipsychotics induced
the accumulation of perinuclear late endolysosomes enriched in both cholesterol and DiI, con-
firming previous results [8]. Addition of curcumin to the medium for just 2 hours decreased
the size of granules positive for DiI, filipin, and CD63. Moreover, curcumin-treated cells
Table 1. Cholesterol content in exosomes secreted by HepG2 cells.
Cholesterol (ng/total extract)
– curcumin + curcumin
Control 119.2 ± 31.6 261.2 ± 36.2***
Haloperidol 145.0 ± 2.5 410.0 ± 32.5****,++++
Clozapine 161.3 ± 16.3 413.8 ± 6.3****,++++
Risperidone 97.5 ± 2.5 331.3 ± 63.8****
Ziprasidone 113.8 ± 8.8 546.3 ± 21.3****,++++
Cells were exposed to LDL (60 μg/ml of cholesterol) in the absence (control) or the presence of antipsychotics (haloperidol, clozapine, risperidone and
ziprasidone, 10 μM) for 16 h. Cells were washed twice, and serum-free medium was added containing the same antipsychotic with or without 30 μM
curcumin, as indicated, and the cells were incubated for additional 2 h. Then, exosomes were isolated from the medium and analyzed by GC/MS. Data
are shown as ng of cholesterol in the total exosomes extract. Results are presented as means ± SEM of 3 independent experiments. Statistical
comparisons are shown curcumin versus no curcumin
(* P<0.05,
** P<0.01,
*** P<0.001 and
**** P<0.0001) or versus control treated with curcumin (
+ P<0.05,
++ P<0.01,
+++ P<0.001 and
++++ P<0.0001).
doi:10.1371/journal.pone.0141829.t001
Fig 7. Effect of curcumin on the incorporation of [3H]oleic acid into cholesterylesters in HepG2 cells
treated with antipsychotics.Cells were exposed to LDL (60 μg/ml of cholesterol) in the absence (control) or
the presence of haloperidol (Hal), clozapine (Clo), risperidone (Ris), or ziprasidone (Zip) (10 μM) for 16 h.
Cells were washed twice and then incubated for additional 2 h in serum-free medium containing the same
antipsychotic with or without curcumin (30 μM) and [3H]oleic acid. Then, cells were collected, lipids extracted
and separated by HPLC. Results are mean ± SEM of three independent experiments. Statistical comparisons
shown antipsychotic versus untreated control (+ P<0.05, ++ P<0.01 and +++ P<0.001).
doi:10.1371/journal.pone.0141829.g007
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exhibited abundant DiI- and filipin-positive vesicles around the cell periphery, suggesting that
curcumin was promoting lipid egress by stimulating exocytosis.
The release of exosomes, which originate from intraluminal vesicles within MVBs [27], may
act to remove materials accumulated in endolysosomes, including lipids and hydrolytic
enzymes [31]. Strauss et al. (2010) reported that both oligodendroglial cells treated with
U18666A and NPC1-deficient fibroblasts secrete cholesterol-containing exosomes, and pro-
posed that exosomal release serves as a mechanism to partially alleviate intracellular cholesterol
trafficking block [32]. In line with this, we found that curcumin stimulated the release of the
lysosomal enzyme β-hexosaminidase into the media, as well as flotillin-2 and CD63, which
both are considered as exosome markers [29,32,40]. Moreover, curcumin increased the secre-
tion of cholesterol and LDL-derived DiI and [3H]-cholesterol, which was associated with the
decrease of the levels of these lipids within the cells. Finally, the release of exosomes to the
medium was confirmed by the identification of particles with the predicted size and morphol-
ogy, as examined by electron microscopy, and the demonstration that extracellular vesicles iso-
lated by ultracentrifugation contained CD63 on their surface, an exosome marker [40]. In cells
loaded with DiI-labeled LDL, these secreted particles also contained DiI, all of which unequivo-
cally demonstrates their endolysosomal origin.
In adipocytes and macrophages, other authors reported that curcumin stimulates choles-
terol efflux, which was attributed to the upregulation of ABCA1 [24,25]. As we use a serum-
free medium containing no detectable ApoA1 to assay cholesterol secretion, the contribution
of this additional mechanism in our experimental conditions should be of less importance. The
unequivocal demonstration that curcumin stimulates exosome secretion suggests that this
mechanism promotes lipid clearance in antipsychotic-treated HepG2 cells, thus contributing
to mitigate the lipid deposition phenotype. Whether other mechanisms also contribute to the
lipid secretion induced by curcumin, however, can not be ruled out.
We asked whether curcumin also stimulates the egress of lysosomal cholesterol to the ER.
For this we measured the cholesterol esterification by ACAT, which is dependent on the cho-
lesterol availability in the ER [14,41]. Treatment with antipsychotics diminished the incorpo-
ration of oleic acid into cholesterol esters, which is in accordance with the inhibition of the
cholesterol egress of cholesterol from the endolysosomal compartment induced by these drugs.
However, curcumin did not mitigate this effect of antipsychotics, indicating that this polyphe-
nol, at least during the studied period, did not facilitate the arrival of free cholesterol to the ER.
Previous studies by others reported the reduction of cellular cholesterol levels by effect of
curcumin in cells in culture [23]. In mice fed a high-fat diet, curcumin also attenuated hepatic
accumulation of cholesterol and triglycerides [42,43]. In N-methyl N-nitrosourea-treated mice,
curcumin administration normalized total lipids, cholesterol, and phospholipids in membrane
preparations from cerebrum and cerebellum [44]. Finally, curcumin also has been shown to
protect against antipsychotics side effects not related to lipid metabolism, such as oro-facial
dyskinesia induced by haloperidol in animal models [45,46], all showing the potential of this
polyphenol for disease prevention.
The mechanism by which curcumin stimulates exosome secretion is not known.
Among other actions, curcumin has been shown to potently inhibit SERCA, thus increasing
cytosolic Ca2+ levels [17] and also activates neutral sphingomyelinase and inhibits sphingomye-
lin synthase, leading to the accumulation of ceramides within the cell [47]. These two agents,
intracellular calcium and ceramides, are involved in exosome release. Thus, Ca2+ has been
shown to accumulate in the MVB upon the stimulation of the secretory process and increasing
intracellular Ca2+ markedly enhances exosome secretion [28]. On the other side, intracellular
production of ceramides has been described to stimulate exosomes generation [48]. Interest-
ingly, the alteration of calcium homeostasis directly affects the sphingolipid trafficking inside
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the cell, followed by the storage of cholesterol in acidic intracellular compartment, which illus-
trates the connection among these factors [20]. Based on these results, it may be speculated that
curcumin stimulates exosome secretion by acting on both Ca2+ calcium homeostasis and sphin-
golipid metabolism, a hypothesis that should be confirmed in future studies.
In conclusion, we show that curcumin accelerates the release of exosomes containing cho-
lesterol from cells with impaired intracellular cholesterol trafficking due to antipsychotic treat-
ment. The egress of cholesterol (and presumably other lipids) out of the cell ameliorated
cholesterol retention within the endolysosomal compartment. This effect of curcumin may
help minimize the adverse metabolic effects associated with chronic antipsychotic treatment.
The low bioavailability of curcumin [49] may limit the extrapolation of present results to the in
vivo condition, which deserves to be further studied and tested in clinical trials.
Supporting Information
S1 File. Fig A: Effect of different doses of curcumin on the intracellular DiI-LDL accumulation
in cells treated with haloperidol. HepG2 cells were incubated with DiI-LDL (30 μg/ml of cho-
lesterol) for 16 h in the absence (control) or the presence of haloperidol (10 μM). Then, cells
were washed and serum-free medium containing the same antipsychotic without or with 5, 10,
30 or 40 μM curcumin was added and incubated for additional 2 h. Intracellular DiI-LDL was
measured by flow cytometry. Results are mean ± SEM of three independent experiments per-
formed in duplicate. M.I.F., median intensity of fluorescence; a.u.f., arbitrary units of fluores-
cence. Statistical comparisons shown are haloperidol versus control for each dose of curcumin
( P<0.05,  P<0.01) and haloperidol with for each dose of curcumin versus haloperidol with-
out curcumin (+ P<0.05, ++ P<0.01). Fig B: Electron micrographs of HepG2 cells treated with
an antipsychotic (clozapine or risperidone at 10 μM) and LDL (60 μg/ml of cholesterol) for a
total of 18 h. Where indicated, during the last 2 h, the cells were treated with 30 μM curcumin.
Images are representative of 2 independent experiments. Lysosomes (▲), lipid inclusions (§),
heterolysosomes or MVB (). Table A: Cholesterol content in HepG2 cells. Cells were exposed
to LDL (60 μg/ml of cholesterol) in the absence (control) or the presence of antipsychotics (hal-
operidol, clozapine, risperidone and ziprasidone, 10 μM) for 16 h. Then the medium was
removed, cells were washed twice, and serum-free medium was added, supplemented or not
(control) with antipsychotics, and incubation was continued for 2 h in the presence of 30 μM
curcumin, as indicated. At the end of the incubation, the cells were lysed, lipids were isolated
and analyzed by GC/MS. Data are shown as ng of cholesterol per mg of protein. Results are
presented as means ± SEM of three independent experiments. Statistical comparisons are
shown curcumin versus without curcumin ( P<0.05,  P<0.01 and  P<0.001) or versus
control without curcumin (+ P<0.05).
(PDF)
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